MEGESTROL Drug Patent Profile
✉ Email this page to a colleague
When do Megestrol patents expire, and when can generic versions of Megestrol launch?
Megestrol is a drug marketed by Chartwell, Hikma, Novitium Pharma, Pharmobedient, Strides Pharma Intl, Teva Pharms, Twi Pharms, Barr, Teva, and Usl Pharma. and is included in fifteen NDAs.
The generic ingredient in MEGESTROL is megestrol acetate. There are eighteen drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the megestrol acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Megestrol
A generic version of MEGESTROL was approved as megestrol acetate by STRIDES PHARMA INTL on August 8th, 1988.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MEGESTROL?
- What are the global sales for MEGESTROL?
- What is Average Wholesale Price for MEGESTROL?
Summary for MEGESTROL
| US Patents: | 0 |
| Applicants: | 10 |
| NDAs: | 15 |
| Drug Prices: | Drug price information for MEGESTROL |
| DailyMed Link: | MEGESTROL at DailyMed |
US Patents and Regulatory Information for MEGESTROL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chartwell | MEGESTROL ACETATE | megestrol acetate | SUSPENSION;ORAL | 204688-001 | Dec 1, 2017 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Teva Pharms | MEGESTROL ACETATE | megestrol acetate | SUSPENSION;ORAL | 075681-001 | May 5, 2003 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Novitium Pharma | MEGESTROL ACETATE | megestrol acetate | SUSPENSION;ORAL | 077404-001 | Feb 16, 2006 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Hikma | MEGESTROL ACETATE | megestrol acetate | TABLET;ORAL | 074458-002 | Sep 29, 1995 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
